Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015.

by Andrzej Śliwczyński, Melania Brzozowska, Andrzej Jacyna, Petre Iltchev, Tymoteusz Iwańczuk, Waldemar Wierzba, Michał Marczak, Katarzyna Orlewska, Piotr Szymański, Ewa Orlewska
Published 2017-01-01